Friday, 30 October 2026 Every NSE & BSE announcement, by company
ALFA Filings Every announcement, straight from the exchange
Merger & Restructuring

Krebs Biochemicals & Industries Merger & Restructuring

Krebs Biochemicals approved a merger with Ipca Laboratories Limited. The amalgamation aims for operational synergies and business consolidation.

Source

NSE filing, NSE: KREBSBIO. Summary written from the filing by ALFA Finder's alert engine.

Read the filing ↗

Krebs Biochemicals & Industries Ltd: key numbers

Share price
₹57.93
Market cap
₹124.9 Cr
Revenue (annual)
₹23.73 Cr
Net profit (annual)
₹-16.93 Cr
P/E (TTM)
-9.4×Sector 48.7×
Promoter holding
72.74%+0.00% QoQ
FII holding
0.50%Current quarter

Reference market data from a third-party provider, updated daily. Not a valuation or a recommendation.

More from Krebs Biochemicals & Industries Ltd

All →

Other merger & restructuring announcements

All →